Poehling Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$755K Buy
4,068
+50
+1% +$9.28K 0.18% 80
2025
Q1
$842K Sell
4,018
-127
-3% -$26.6K 0.21% 80
2024
Q4
$737K Sell
4,145
-34
-0.8% -$6.04K 0.18% 84
2024
Q3
$825K Sell
4,179
-28
-0.7% -$5.53K 0.21% 79
2024
Q2
$722K Sell
4,207
-9,058
-68% -$1.55M 0.2% 81
2024
Q1
$2.42M Sell
13,265
-387
-3% -$70.5K 0.65% 49
2023
Q4
$2.12M Sell
13,652
-3,815
-22% -$591K 0.67% 52
2023
Q3
$2.6M Buy
17,467
+227
+1% +$33.8K 0.91% 33
2023
Q2
$2.32M Sell
17,240
-23,368
-58% -$3.15M 0.78% 41
2023
Q1
$6.47M Sell
40,608
-625
-2% -$99.6K 2.18% 10
2022
Q4
$6.66M Buy
41,233
+510
+1% +$82.4K 2.5% 7
2022
Q3
$5.47M Sell
40,723
-282
-0.7% -$37.8K 2.29% 16
2022
Q2
$6.28M Sell
41,005
-975
-2% -$149K 2.36% 14
2022
Q1
$6.81M Sell
41,980
-437
-1% -$70.8K 2.1% 12
2021
Q4
$5.74M Sell
42,417
-653
-2% -$88.4K 1.85% 14
2021
Q3
$4.65M Buy
43,070
+3,641
+9% +$393K 1.57% 18
2021
Q2
$4.44M Buy
39,429
+263
+0.7% +$29.6K 1.41% 19
2021
Q1
$4.24M Buy
39,166
+3,038
+8% +$329K 1.48% 16
2020
Q4
$3.87M Buy
36,128
+55
+0.2% +$5.89K 1.54% 17
2020
Q3
$3.16M Buy
36,073
+618
+2% +$54.1K 1.62% 15
2020
Q2
$3.48M Buy
35,455
+220
+0.6% +$21.6K 1.87% 12
2020
Q1
$2.69M Buy
35,235
+10,695
+44% +$815K 1.97% 12
2019
Q4
$2.17M Buy
24,540
+525
+2% +$46.5K 1.42% 20
2019
Q3
$1.82M Buy
24,015
+9,309
+63% +$705K 1.33% 23
2019
Q2
$1.07M Buy
14,706
+840
+6% +$61.1K 0.72% 47
2019
Q1
$1.12M Buy
13,866
+210
+2% +$16.9K 0.81% 48
2018
Q4
$1.26M Buy
13,656
+5,391
+65% +$497K 1.21% 24
2018
Q3
$782K Buy
8,265
+3,840
+87% +$363K 0.55% 53
2018
Q2
$410K Sell
4,425
-3,815
-46% -$353K 0.36% 69
2018
Q1
$780K Hold
8,240
0.63% 50
2017
Q4
$797K Buy
+8,240
New +$797K 0.68% 49